This a great news. I cant afford vyvanse with no insurance. Maybe i can finally get back on medication. I wonder how long it takes to get on the market now that it's been approved.
When I was on my parents insurance, the first 1-2 fills of the year were $11/pill and ~$1.20/pill after that (20mg). Now that I'm on my own insurance, it's $2.50/pill year round.
That means if I take it every day, it's ~$900/year
Jesus, it's insane... I'm in Quebec, my Vyvanse and Escitalopram together cost me less than $40/month w/ 80% coverage, so about $200 if I paid out of pocket...
U.S.-based drugmakers Mallinckrodt (MCD0.F) and Viatris (VTRS.O), UK-based Hikma Pharmaceuticals (HIK.L) and Indian drugmaker Sun Pharmaceutical Industries (SUN.NS) confirmed on Thursday they began shipping their generic versions of the drug
A friend who is a tech at a Costco pharmacy told me yesterday that they are expecting a shipment of the generic to arrive today. While my pharmacy has no ETA on the name brand and does not have access to the generic from their distributors as far as I have been able to surmise.
I know the pharmacy I'm currently trying to get it filled at originally tried to fill the generic but didn't have it. (Obviously this was yesterday) and the issue was they weren't sure if my insurance would pay for name brand... I had to explain that it was okay to bill for name brand.
I haven't been able to find any since mid July. Literally every pharmacy is out. Even the independents. Fucking ridiculous. At least I have an old stash Adderall to keep me semi functional.
Awesome! I know folks who preferred this but had to stop taking it because insurance hates covering medicine that has an alternative that has a generic.
I am one of those people. Been managing this issue for 20 plus years and all the sudden new insurance company has me on trash Adderall which has not ever been a good for for me...but they know best. Hopefully I can get generic Vyvanse.
For those who are currently taking it and having issues paying for it, Vyvanse offers a coupon for your prescription for $30. https://www.vyvanse.com/coupon
Ah. Gotcha. I realize how lucky we were that it was only $80/month with insurance. We were the lucky ones who got it down to $30/month with the coupon. I do not remember what insurance we had, and this was years ago as well.
Please note that VYVANSE and MYDAYIS will no longer be available through Help at Hand after December 31, 2023. The completed application with all required supporting documentation must be received and approved by October 16, 2023 in order to continue to receive product from the Help at Hand Patient Assistance Program for the remainder of 2023. Please work with your health care provider to determine the appropriate next steps to best address your individual needs. Enrollees with questions should call 1-800-830-9159.
I have only heard good things about Vyvanse. But I don't know as many people who have tried it because it's been expensive for many people. I'm hoping these approved generics get to market fast! I've been struggling without my Adderall XR - the shortage finally caught up to me.
It's good in that it is more consistent during the day due to how it works and is absorbed by the body. For some that Adderall didn't work (or stopped working) Vyvanse was a good alternative, but at a much higher cost.
Not 100% on this source, but it's the only one which I found which described how Vyvance acts and why it's different from Adderall:
Adderall contains amphetamine salts directly while Vyvanse uses lisdexamfetamine as a “prodrug,” which gets converted into an active form in the body before it has any effects. This extra step makes its side effects less pronounced than those taking Adderall.
Adderall is more common as the patent expired in 2009 and it has had generics for over a decade. This has brought the 30-day supply price of Adderall to $10-$40. Meanwhile Vyvanse:
Takeda, for its part, has ratcheted up the cost of ADHD superstar Vyvanse 19 times since its market debut in 2007. A bottle initially cost $341 before rebates and discounts, but after January’s hike, the list price is now an “astounding” $1,172, the patient group said.